Giroctocogene Fitelparvovec Uses, Dosage, Side Effects and more
Giroctocogene Fitelparvovec is under investigation in clinical trial NCT04370054 (Study to Evaluate the Efficacy and Safety of PF-07055480 in Moderately Severe to Severe Hemophilia a Adults).
| Trade Name | Giroctocogene Fitelparvovec |
| Generic | Giroctocogene fitelparvovec |
| Giroctocogene fitelparvovec Other Names | Aav2/6-b-domain-deleted blood coagulation factor viii, Dna (recombinant adeno-associated virus 6 vector pf-07055480 human b-domain-deleted blood-coagulation factor viii-specifying), Giroctocogene fitelparvovec |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
